Search tips
Search criteria 


Logo of canjpsychThe Canadian Journal of Psychiatry
Can J Psychiatry. 2014 January; 59(1): 18–25.
PMCID: PMC4079223

Language: English | French

Neurocognitive Vulnerability: Suicidal and Homicidal Behaviours in Patients With Schizophrenia

Stéphane Richard-Devantoy, MD, PhD,1 Manuel Orsat, MD,2 Alexandre Dumais, MD, PhD,3 Gustavo Turecki, MD, PhD,4 and Fabrice Jollant, MD, PhD5



Schizophrenia is associated with an increase in the risk of both homicide and suicide. The objectives of this study were to systematically review all published articles that examined the relation between neurocognitive deficits and suicidal or homicidal behaviours in schizophrenia, and to identify vulnerabilities in suicidal and homicidal behaviour that may share a common pathway in schizophrenia.


A systematic review of the literature was performed using MEDLINE to include all studies published up to August 31, 2012.


Among the 1760 studies, 7 neuropsychological and 12 brain imaging studies met the selection criteria and were included in the final analysis. The neuropsychological and functional neuroimaging studies were inconclusive. The structural imaging studies reported various alterations in patients with schizophrenia and a history of homicidal behaviour, including: reduced inferior frontal and temporal cortices, increased mediodorsal white matter, and increased amygdala volumes. Patients with a history of suicidal acts showed volumetric reductions in left orbitofrontal and superior temporal cortices, while right amygdala volume was increased, though, these findings have rarely been replicated. Finally, no study has directly compared neurocognitive markers of suicidal and homicidal risk.


These results suggest that brain alterations, in addition to those associated with schizophrenia, may predispose some patients to a higher risk of homicide or suicide in particular circumstances. Moreover, some of these alterations may be shared between homicidal and suicidal patients. However, owing to several limitations, including the small number of available studies, no firm conclusions can be drawn and further investigations are necessary.

Keywords: schizophrenia, suicide, homicide, executive functions, amygdala, systematic review


Objectif :

La schizophrénie est associée à un risque accru d’homicide et de suicide. Cette étude avait pour objectifs de mener une revue systématique de tous les articles publiés qui ont examiné la relation entre les déficiences neurocognitives et les comportements suicidaires ou homicides dans la schizophrénie, et d’identifier les vulnérabilités du comportement suicidaire et homicide qui peuvent partager une trajectoire commune dans la schizophrénie.

Méthodes :

Une recherche systématique de la littérature a été effectuée dans MEDLINE pour inclure toutes les études publiées jusqu’au 31 août 2012.

Résultats :

Parmi les 1760 études, 7 études neuropsychologiques et 12 études d’imagerie cérébrale satisfaisaient aux critères de sélection et ont été incluses dans l’analyse finale. Les études de neuroimagerie fonctionnelle et neuropsychologiques n’étaient pas concluantes. Les études d’imagerie structurelle rapportaient des altérations variées chez les patients souffrant de schizophrénie et ayant des antécédents de comportement homicide, notamment : des cortex frontal et temporal inférieurs réduits, une matière blanche médiodorsale accrue, et des volumes d’amygdale plus larges. Les patients ayant des antécédents de gestes suicidaires présentaient des réductions volumétriques dans le cortex orbitofrontal gauche et le cortex temporal supérieur, alors que le volume de l’amygdale droite était accru, bien que ces résultats aient rarement été reproduits. Enfin, aucune étude n’a comparé directement les marqueurs neurocognitifs du risque de suicide et d’homicide.

Conclusion :

Ces résultats suggèrent que les altérations du cerveau, outre celles associées à la schizophrénie, peuvent prédisposer certains patients à un risque plus élevé d’homicide ou de suicide dans des circonstances particulières. De plus, certaines de ces altérations peuvent être partagées entre les patients homicides et suicidaires. Cependant, en raison de plusieurs limitations, dont le nombre réduit d’études disponibles, aucune conclusion déterminante ne peut être tirée et plus de recherche est nécessaire.

Suicide and homicide are major public health concerns. According to the World Health Organization,1 one million people die by suicide, and 10 to 20 times more people attempt suicide each year around the world. Further, more than half a million people die by homicide each year worldwide.2,3 These acts represent a significant cost to the people involved, their families, and society as a whole.4

To date, several risk factors for suicide and homicide have been identified, the most significant of which is the presence of psychiatric disorders.58 Among these, schizophrenia, one of the most debilitating psychiatric disorders, is associated with increased risks of both death by suicide9 and committing homicide.10 Suicide is one of the main causes of premature death among these people (10% to 15% die by suicide).11 A recent meta-analysis also confirmed that the risk of homicide is 20-fold among patients with schizophrenia, compared with healthy control subjects.10 In line with this, it has been estimated that 6% of murderers suffer from schizophrenia.57 Although schizophrenia increases the risk of both suicide and homicide, only a few patients with schizophrenia will die by suicide or commit homicide. Therefore, schizophrenia alone is insufficient to explain the full suicidal or homicidal risk.

Additional risk factors for suicidal and homicidal behaviours have been identified in patients with schizophrenia, several of which are identical for both behaviours.6,10,12,13 These factors include being male, younger age,1318 low educational level, low level or absence of a professional activity,1925 alcohol abuse,12,26,27 and a history of childhood physical abuse.13,28,29 Impulsivity has also been shown to be a major risk factor of suicide30 and aggression31 in schizophrenia. Moreover, a history of suicide attempts is the strongest predictive factor of future suicide completion,8,3234 and a prior history of any violent offence is the strongest predictive factor of future homicide.6,10,12,13

Clinical Implications

  • Investigating neurocognitive deficits may become part of a more comprehensive assessment of suicidal and homicidal risk among patients with schizophrenia.
  • Neurocognitive deficits may be the target of future interventions to reduce the suicidal and homicidal risk among patients with schizophrenia.


  • To date, a limited number of studies have investigated the neurocognitive markers of suicidal and homicidal risk among patients with schizophrenia.
  • Similarly, a limited number of cognitive domains have been assessed in these patients to this specific aim.
  • No study has directly compared neurocognitive markers of suicidal and homicidal risk.

These sociodemographic and clinical findings support 2 hypotheses: both suicidal and homicidal behaviours may have specific underlying vulnerabilities distinct from those of schizophrenia; and some of these vulnerabilities may be shared between both suicidal and homicidal behaviours. However, the large number of clinical risk factors of suicidal and homicidal behaviours and the complexity of their interactions limit our ability to predict these behaviours in people suffering from schizophrenia (that is, schizophrenia, schizoaffective, or schizophreniform disorders diagnosed as per the DSM-IV criteria). To overcome this issue, we need to explore other ways, such as neurocognitive impairment, which may be more sensitive in detecting vulnerabilities to these complex acts, keeping in mind that schizophrenia, per se, is associated with a range of cognitive deficits.35 In mood disorders, neuropsychological and neuroimaging studies have yielded interesting findings regarding the neurocognitive basis of the vulnerability to suicidal behaviour.36

Our paper aims to identify the specific neurocognitive factors (from neuropsychological and neuroimaging studies) of suicidal and homicidal behaviours in people with schizophrenia, and to examine possible shared pathways between suicidal and homicidal risk at the neurocognitive level. A systematic literature review was performed to synthesize all published articles assessing the association between neurocognitive markers and suicidal and homicidal behaviours in people suffering from schizophrenia. Both neuroimaging and neuropsychological studies were reviewed. Based on previous findings in suicidal behaviour of mood disorders,36 and on the observation that many risk factors for suicide or homicide are shared across diagnoses,37 we expect patients with schizophrenia and histories of suicidal behaviour or homicide to show impaired decision making and cognitive inhibition in relation to amygdala and orbitofrontal, dorsomedial, and dorsolateral prefrontal cortices impairment.


Literature Search

We performed a systematic MEDLINE literature search of all clinical trials, cohort, case–control, and cross-sectional human studies published in English until August 31, 2012. The MeSH terms “schizophrenia” and “psychotic disorders” were combined with the MeSH terms “violence,” “homicide,” and “suicide.” Then, these were combined with the MeSH terms and with the TIAB terms of neurocognitive pathways. To explore the neurocognitive pathways of suicide and homicide, the following MeSH terms were used: “cognition,” “neuropsychology,” “neuropsychological tests,” “executive function,” “decision making,” “problem solving,” “magnetic resonance imaging,” “diffusion magnetic resonance imaging,” “positron-emission tomography,” “prefrontal cortex,” “tomography, emission-computed, single-photon,” and “diffusion tensor imaging.” TIAB terms also included “neuropsychological functions,” “executive functioning,” “executive performance,” and “neuroimaging.” For completeness, the search also included the Embase database (Ovid interface) from January 1, 1996, to August 31, 2012. An iterative process was used to ensure that all relevant articles were obtained. We also performed a manual search of bibliographical references of extracted papers and existing reviews to identify potential studies not captured in the electronic database searches.

Study Selection

Abstract selection was based on the STROBE checklist,38 which describes items that should be included in reports of cohort studies. Our review followed the STROBE statement guidelines. Abstracts identified through the literature search were independently evaluated by 2 authors for meeting the inclusion criteria. The quality of each study was assessed independently by 2 authors using the Crombie criteria adapted by Petticrew and Roberts.39 Disagreements were resolved by a third author.

Titles, abstracts, and manuscripts were only included in the analyses if they met all of the following 4 inclusion criteria: published in a peer-reviewed, English-language journal; included people with schizophrenia, schizoaffective, or schizophreniform disorders diagnosed as per the DSM-IV criteria; included at least 1 neuropsychological task or an MRI; compared at least 2 groups of patients, one of which comprised patients with a history of suicide attempts (defined as any act carried out with a certain intent to die and different from self-mutilation37) or with a history of homicide (defined as fatal injuries inflicted by a person with intent to injure or kill another person2). The study selection process is shown on a chart flow diagram in Figure 1.

Figure 1
Selection of neuropsychological and neuroimaging studies in patients with schizophrenia at risk of suicidal or homicidal behaviours


The systematic literature review identified 7 neuropsychological studies (eTable 1) and 12 brain imaging studies (eTable 2).

Neuropsychological Studies

Three studies explored executive functions in relation to homicide in schizophrenia (for a total of 82 patients with a history of homicidal behaviour, 89 patient control subjects, and 61 healthy control subjects) (Table 3). In comparison to patients with schizophrenia without such a history, patients with schizophrenia and a history of homicidal behaviour performed more poorly on several executive functions, including mental shifting, cognitive inhibition, and verbal fluency.40 In addition, executive deficits were more common in people with schizophrenia regardless of their history of violence, compared with patients with antisocial personality disorder only.40 However, 2 other studies reported no such group differences.41,42

Table 3
Neurocognitive performances associated with homicidal and suicidal vulnerability in schizophrenia

In the case of suicidal behaviour, 5 studies were found (including 1 prospective study) that showed contradictory results (328 patients with a history of suicidal behaviour; 453 patient control subjects). In 2 studies, outpatient suicide attempters with schizophrenia tended to outperform nonattempters with schizophrenia in executive functioning, namely, on measures of attention and verbal fluency,43 and cognitive flexibility.43,44 However, the 3 other studies did not find any group difference in executive performances.4547

Neuroimaging Studies

Structural Neuroimaging Studies

Five studies were found in relation to homicidal risk (130 patients with a history of homicidal behaviour, 114 patient control subjects). Patients with schizophrenia and with a prior homicide history showed various brain structural abnormalities, including reduced whole brain volume,48 cortical thinning,4951 particularly in the medial inferior frontal cortex,49,51 a decrement of temporal48,51 and hippocampus volumes,52 an increment in the volume of the amygdala and the putamen,48 a reduction in the volume of the sensorimotor areas,49 a reduction in the volume of the grey matter in the cerebellum, angular gyrus, and supramarginal gyrus,50 a reduction in the grey matter volume in the right parahippocampal gyrus, and a grey matter augmentation in the mediofrontal cortex,52 compared with patients with no history of homicidal behaviours.

Regarding suicidal acts, 3 studies were found (37 patients with a history of suicidal behaviour, 105 patient control subjects, and 100 healthy control subjects). In patients with schizophrenia and a history of suicide attempt(s), compared with patients with schizophrenia and no suicidal history, there was a significant reduction in the grey matter volume in the left superior temporal lobe and in the left orbitofrontal cortex.53 In addition, there was evidence of significantly larger inferior frontal white matter volumes bilaterally.54 There was also a selective increase in volume in the right amygdala of patients with a history of suicidal acts, compared with patients without such history and with healthy control subjects.55

Functional Neuroimaging Studies

We found 4 functional neuroimaging studies pertaining patients with homicidal behaviours. These studies reported reduced activation in the right frontal and inferior parietal areas in a working memory paradigm,56 and greater activation in the left medial frontal–cingulate gyrus and bilaterally in the temporal-occipital regions in an experimental manipulation of anticipatory fear induction,57 in patients with schizophrenia with previous homicidal acts, compared with those without. Violent patients with schizophrenia with both comorbid antisocial personality and SUD failed to show higher blood flow in the orbital or basal regions during the inhibition part of the go–no-go task, compared with patients with schizophrenia only and with nonviolent healthy control subjects.58 Further, significantly higher activation in frontal motor, premotor, and anterior cingulate regions were observed in this particular group, compared with patients with schizophrenia only.

No functional neuroimaging studies were found in relation to suicidal acts in patients with schizophrenia.


Our study provides the first systematic literature review, revealing the following findings:

  1. a paucity of available data regarding the neurocognitive markers of homicidal and suicidal risk in patients with schizophrenia, which contrasts with the accumulating data in mood disorders36;
  2. although the neuropsychological and functional neuroimaging studies were inconclusive, structural neuroimaging studies generally support the existence of alterations in patients with a history of suicidal or homicidal acts, compared with patients with no history; and
  3. no study has directly compared suicidal and homicidal patients.

Before a detailed discussion of these findings, we must start by highlighting several main limitations. First, the number of studies available, to date, is small, particularly the ones investigating suicidal acts, thus hindering any definitive conclusions. We selected only studies that compared at least 2 groups of patients; one comprised of patients with either a history of suicide attempts or a history of homicide. This is the best way to evaluate specific vulnerability to suicidal and homicidal behaviour in schizophrenia. Second, the populations studied were very heterogeneous in terms of sociodemographic and clinical characteristics. For instance, some studies included only male subjects,40,42,48,49,51,53,5658 whereas others grouped male and female participants together.41,43,44,46,50,54,55,5964 Additional limitations include the small sample sizes; the lack of information on substance abuse or medication; the variability of the primary diagnosis42,46,61,62; and that comorbid antisocial personality disorder was often not assessed.40,48,49,56,58 Moreover, the severity of the psychopathology of a subject, the recurrence of psychotic episodes, as well as the age of the first episode psychosis, are often omitted and may also influence the variability of results. Moreover, substance abuse in schizophrenia is associated with an increased risk of violent homicide in longitudinal studies12,65 and with suicidal behaviour.18

The definitions of suicidal and homicidal behaviours were also heterogeneous. The studies included patients with a history of suicide attempts,43,46,5355,63 suicide attempters with suicidal ideations,44,62 patients who had committed homicide,58 patients with a history of severe violence, including homicide and attempted homicide.41,42,50,59,64,66 Additionally, some authors differentiated severe from less severe suicidal and homicidal acts.

The methodology of the studies reviewed also varied. For instance, the delay between the suicidal or the homicidal act and the neuropsychological assessment varied. The tools used to assess suicidal and homicidal behaviours and neurocognitive markers also differed. For example, homicidal behaviour was evaluated using the Gunn and Robertson scale, with a cut-off score of 440,48,56 or 5.51,57 In addition, while some authors used only a single neuropsychological test to evaluate cognitive processes, others used a larger battery of tests.

Despite these limitations, there are several important implications that can be derived from our review. First, more homogeneity in assessment is required if we are to understand the neurocognitive basis of the vulnerability to homicidal and suicidal risks in schizophrenia. Second, many more neuropsychological and neuroimaging studies are needed. Data from mood disorders largely support the concept of vulnerability to suicidal behaviour, including but not limited to impairment in decision making67,68 and cognitive inhibition.6972 In addition, structural and functional neuroimaging have implicated several brain regions, including the orbifrontal, dorsolateral, and dorsomedial prefrontal cortices.36 These cognitive deficits and brain dysfunctions may become part of future assessments and the target of future interventions to reduce the suicidal or homicidal risks.

Among the studies published to date pertaining to patients with schizophrenia and a history of suicidal or homicidal acts, most findings come from structural neuroimaging. Nine studies investigated the homicidal risk in schizophrenia and reported reduced inferior frontal and temporal volume, and increased amygdala volume.48 These results are consistent with previous studies implicating these regions with psychopathy scores, history of violence, antisocial personality disorder diagnosis, or impulsiveness.57,58,73,74 A recent meta-analysis suggested that patients with a history of violent behaviour, including homicide, were associated with significantly reduced prefrontal structure and function (right orbitofrontal cortex, right anterior cingulate cortex, and left dorsolateral prefrontal cortex).75 Moreover, in the review by Naudts and Hodgins,76 male patients with schizophrenia who consistently showed a pattern of aggressive and antisocial behaviour had poorer orbitofrontal functions, an increased size of the putamen, and reduced volumes of the amygdala, the hippocampus, and the orbitofrontal cortex, compared with patients with schizophrenia with no history of violence.

Literature also suggests that, among patients with schizophrenia, those who present with conduct problems from childhood onward perform better on tests assessing specific executive functions. However, they also perform more poorly on assessments of orbitofrontal functions, show fewer neurological soft signs, display larger reductions in the amygdala volume, more structural abnormalities in the orbitofrontal cortex, more abnormalities of white matter in the amygdala–orbitofrontal cortex, and smaller reductions of the hippocampus.76 Only one study58 explored neurocognitive pathways of homicidal behaviour and tried to distinguish subtypes of homicide offenders who differ in comorbidity associated with schizophrenia. Using functional MRI, they showed homicidal people with schizophrenia and comorbid antisocial personality disorder and SUD would present a different pattern of prefrontal functioning than homicidal people with schizophrenia only. Frontal basal cortices were significantly less activated in people with schizophrenia and comorbidity during the execution of a go–no-go task than in people with schizophrenia only and nonviolent people without mental illness. In contrast, significantly higher activations in frontal motor, premotor, and anterior cingulate regions were observed in the schizophrenia plus comorbidity group than in the schizophrenia only group.58 More studies are needed to disentangle possible subtypes of homicidal histories and their neural basis.

Fewer results were found in patients with histories of suicidal acts. Interestingly, decreased orbitofrontal and temporal cortical volumes, and increased amygdala volume were reported, suggesting partial overlap with vulnerability to homicidal behaviour. Also, decreased orbitofrontal cortex volume and increased amygdala volume,77 and altered orbitofrontal cortex activation78 were found in patients with a mood disorder and a history of suicidal behaviour. Biochemical alterations were also found in the orbitofrontal cortex of depressed suicide completers.79 Taken together, these findings suggest that some brain alterations occur across diagnoses.


Schizophrenia is associated with numerous cognitive and brain alterations.80 Our study suggests, without confirming, that particular brain alterations may add to other disease-related deficits (for example, hallucination and temporal cortex) to affect a patient’s ability to perceive and respond adequately to their environment. Specific deficits in the prefrontal–limbic circuitry may predispose some patients with schizophrenia to homicidal behaviour or to suicidal behaviour.

More studies are needed and future research should directly compare neurocognitive markers of suicidal and homicidal risk. Cohort studies are also necessary to determine the predictive power of these markers. Finally, targeting these deficits may be part of future therapeutic interventions in at-risk patients.

Supplementary Material

eTable 1

eTable 2


None of the authors have any competing financial interests for this manuscript. Dr Richard-Devantoy received a grant from the Canadian Institute for Health Research. Dr Turecki and Dr Jollant received a salary grant from the Fond de Recherche du Québec—Santé (FRQS). Dr Dumais received a fellowship grant from the FRSQ. None of the funding bodies influenced the project, the analyses, and the publication of this article.


Diagnostic and Statistical Manual of Mental Disorders
Medical Subject Heading
magnetic resonance imaging
STrengthening the Reporting of OBservational studies in Epidemiology
substance use disorder
Title and Abstract


1. Reza A, Mercy JA, Krug E. Epidemiology of violent deaths in the world. Inj Prev. 2001;7:104–111. [PMC free article] [PubMed]
2. World Health Organization (WHO) Rapport mondial sur la violence et la santé = World report on violence and health [Internet] Geneva (CH): WHO; 2002. Oct 3, [date cited unknown]. Available from:
3. Abbadi-Simon S, Gourevitch R, Guelfi JD. EMC Psychiatrie. Paris (FR): Elsevier Masson SAS; 2000. Outils d’évaluation de la qualité de vie; p. 8.
4. Murray C, Lopez A. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge (MA): Harvard University Press; 1996. Global Burden of Disease and Injury Series, vol 1.
5. Fazel S, Grann M. The population impact of severe mental illness on violent crime. Am J Psychiatry. 2006;163(8):1397–1403. [PubMed]
6. Fazel S, Gulati G, Linsell L, et al. Schizophrenia and violence: systematic review and meta-analysis. PLoS Med. 2009;6(8):e1000120. [PMC free article] [PubMed]
7. Hodgins S. Mental disorder, intellectual deficiency, and crime. Evidence from a birth cohort. Arch Gen Psychiatry. 1992;49(6):476–483. [PubMed]
8. Hawton K, van Heeringen K. Suicide. Lancet. 2009;373(9672):1372–1381. [PubMed]
9. Meltzer HY. Suicide in schizophrenia: risk factors and clozapine treatment. J Clin Psychiatry. 1998;59(Suppl 3):15–20. [PubMed]
10. Large M, Smith G, Nielssen O. The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: a systematic review and meta-analysis. Schizophr Res. 2009;112(1–3):123–129. [PubMed]
11. Gale CR, Batty GD, Osborn DP, et al. Association of mental disorders in early adulthood and later psychiatric hospital admissions and mortality in a cohort study of more than 1 million men. Arch Gen Psychiatry. 2012;69(8):823–831. [PMC free article] [PubMed]
12. Fazel S, Langstrom N, Hjern A, et al. Schizophrenia, substance abuse, and violent crime. JAMA. 2009;301(19):2016–2023. [PMC free article] [PubMed]
13. Elbogen EB, Johnson SC. The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2009;66(2):152–161. [PubMed]
14. Dubreucq JL, Joyal C, Millaud F. Risque de violence et troubles mentaux graves. Ann Med Psychol (Paris) 2005;163(10):852–865.
15. Fazel S, Grann M, Carlstrom E, et al. Risk factors for violent crime in schizophrenia: a national cohort study of 13,806 patients. J Clin Psychiatry. 2009;70(3):362–369. [PubMed]
16. Osby U, Correia N, Brandt L, et al. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 2000;45(1–2):21–28. [PubMed]
17. De Hert M, McKenzie K, Peuskens J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr Res. 2001;47(2–3):127–134. [PubMed]
18. Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol. 2010;24(4 Suppl):81–90. [PMC free article] [PubMed]
19. Fischer SN, Shinn M, Shrout P, et al. Homelessness, mental illness, and criminal activity: examining patterns over time. Am J Community Psychol. 2008;42(3–4):251–265. [PubMed]
20. Eriksson A, Romelsjo A, Stenbacka M, et al. Early risk factors for criminal offending in schizophrenia: a 35-year longitudinal cohort study. Soc Psychiatry Psychiatr Epidemiol. 2011;46(9):925–932. [PubMed]
21. Ran MS, Chen S, Chen EY, et al. Risk factors for poor work functioning of persons with schizophrenia in rural China. Soc Psychiatry Psychiatr Epidemiol. 2011;46(11):1087–1093. [PubMed]
22. Ran MS, Chen PY, Liao ZG, et al. Criminal behavior among persons with schizophrenia in rural China. Schizophr Res. 2010;122(1–3):213–218. [PMC free article] [PubMed]
23. Swanson JW, Holzer CE, 3rd, Ganju VK, et al. Violence and psychiatric disorder in the community: evidence from the Epidemiologic Catchment Area surveys. Hosp Community Psychiatry. 1990;41(7):761–770. [PubMed]
24. Caldwell CB, Gottesman II. Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr Bull. 1990;16(4):571–589. [PubMed]
25. Fenton WS, McGlashan TH, Victor BJ, et al. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders. Am J Psychiatry. 1997;154(2):199–204. [PubMed]
26. Brennan PA, Mednick SA, Hodgins S. Major mental disorders and criminal violence in a Danish birth cohort. Arch Gen Psychiatry. 2000;57(5):494–500. [PubMed]
27. Tiihonen J, Isohanni M, Rasanen P, et al. Specific major mental disorders and criminality: a 26-year prospective study of the 1966 northern Finland birth cohort. Am J Psychiatry. 1997;154(6):840–845. [PubMed]
28. Hodgins S, Tiihonen J, Ross D. The consequences of conduct disorder for males who develop schizophrenia: associations with criminality, aggressive behavior, substance use, and psychiatric services. Schizophr Res. 2005;78(2–3):323–335. [PubMed]
29. Haute Autorité de santé (HAS) Dangerosité psychiatrique: étude et évaluation des facteurs de risque de violence hétéro-agressive chez les personnes ayant des troubles schizophréniques ou des troubles de l’humeur [Internet] Paris (FR): HAS; 2011. [cited 2011 Dec 10]. Available from:
30. Iancu I, Bodner E, Roitman S, et al. Impulsivity, aggression and suicide risk among male schizophrenia patients. Psychopathology. 2010;43(4):223–229. [PubMed]
31. Dumais A, Potvin S, Joyal C, et al. Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disorders. Schizophr Res. 2011;130(1–3):234–237. [PubMed]
32. Suominen K, Isometsa E, Suokas J, et al. Completed suicide after a suicide attempt: a 37-year follow-up study. Am J Psychiatry. 2004;161(3):562–563. [PubMed]
33. Kelly DL, Shim JC, Feldman SM, et al. Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death. J Psychiatr Res. 2004;38(5):531–536. [PubMed]
34. Rossau CD, Mortensen PB. Risk factors for suicide in patients with schizophrenia: nested case–control study. Br J Psychiatry. 1997;171:355–359. [PubMed]
35. Rodriguez-Jimenez R, Bagney A, Moreno-Ortega M, et al. [Cognitive deficit in schizophrenia: MATRICS Consensus Cognitive Battery] Rev Neurol. 2012;55(9):549–555. Spanish. [PubMed]
36. Jollant F, Lawrence NL, Olie E, et al. The suicidal mind and brain: a review of neuropsychological and neuroimaging studies. World J Biol Psychiatry. 2011;12(5):319–339. [PubMed]
37. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci. 2003;4:819–828. [PubMed]
38. Von Elm E, Altman DG, Egger M, et al. STROBE Initiative The STrengthening the Reporting of OBservational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–349. [PubMed]
39. Petticrew M, Roberts H. Systematic reviews in the social sciences: a practical guide. Oxford (GB): Blackwell; 2006.
40. Barkataki I, Kumari V, Das M, et al. A neuropsychological investigation into violence and mental illness. Schizophr Res. 2005;74(1):1–13. [PubMed]
41. Lafayette JM, Frankle WG, Pollock A, et al. Clinical characteristics, cognitive functioning, and criminal histories of outpatients with schizophrenia. Psychiatr Serv. 2003;54(12):1635–1640. [PubMed]
42. Silver H, Goodman C, Knoll G, et al. Schizophrenia patients with a history of severe violence differ from nonviolent schizophrenia patients in perception of emotions but not cognitive function. J Clin Psychiatry. 2005;66(3):300–308. [PubMed]
43. Nangle JM, Clarke S, Morris DW, et al. Neurocognition and suicidal behaviour in an Irish population with major psychotic disorders. Schizophr Res. 2006;85:196–200. [PubMed]
44. Kim C, Jayathilake K, Meltzer F. Hopelessness, neurocognitive function, and insight in schizophrenia: a relationship to suicidal behavior. Schizophr Res. 2003;60:71–80. [PubMed]
45. Potkin SG, Anand R, Alphs L, et al. Neurocognitive performance does not correlate with suicidality in schizophrenic and schizoaffective patients at risk for suicide. Schizophr Res. 2003;59(1):59–66. [PubMed]
46. Barrett EA, Sundet K, Simonsen C, et al. Neurocognitive functioning and suicidality in schizophrenia spectrum disorders. Compr Psychiatry. 2011;52(2):156–163. [PubMed]
47. Delaney C, McGrane J, Cummings E, et al. Preserved cognitive function is associated with suicidal ideation and single suicide attempts in schizophrenia. Schizophr Res. 2012;140(1–3):232–236. [PubMed]
48. Barkataki I, Kumari V, Das M, et al. Volumetric structural brain abnormalities in men with schizophrenia or antisocial personality disorder. Behav Brain Res. 2006;169(2):239–247. [PubMed]
49. Narayan VM, Narr KL, Kumari V, et al. Regional cortical thinning in subjects with violent antisocial personality disorder or schizophrenia. Am J Psychiatry. 2007;164(9):1418–1427. [PMC free article] [PubMed]
50. Puri BK, Counsell SJ, Saeed N, et al. Regional grey matter volumetric changes in forensic schizophrenia patients: an MRI study comparing the brain structure of patients who have seriously and violently offended with that of patients who have not. BMC Psychiatry. 2008;8(Suppl 1):S6. [PMC free article] [PubMed]
51. Kumari V, Barkataki I, Goswami S, et al. Dysfunctional, but not functional, impulsivity is associated with a history of seriously violent behaviour and reduced orbitofrontal and hippocampal volumes in schizophrenia. Psychiatry Res. 2009;173(1):39–44. [PubMed]
52. Yang Y, Raine A, Han CB, et al. Reduced hippocampal and parahippocampal volumes in murderers with schizophrenia. Psychiatry Res. 2010;182(1):9–13. [PMC free article] [PubMed]
53. Aguilar EJ, Garcia-Marti G, Marti-Bonmati L, et al. Left orbitofrontal and superior temporal gyrus structural changes associated to suicidal behavior in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(7):1673–1676. [PubMed]
54. Rusch N, Spoletini I, Wilke M, et al. Inferior frontal white matter volume and suicidality in schizophrenia. Psychiatry Res. 2008;164(3):206–214. [PubMed]
55. Spoletini I, Piras F, Fagioli S, et al. Suicidal attempts and increased right amygdala volume in schizophrenia. Schizophr Res. 2011;125(1):30–40. [PubMed]
56. Kumari V, Aasen I, Taylor P, et al. Neural dysfunction and violence in schizophrenia: an fMRI investigation. Schizophr Res. 2006;84(1):144–164. [PubMed]
57. Kumari V, Das M, Taylor PJ, et al. Neural and behavioural responses to threat in men with a history of serious violence and schizophrenia or antisocial personality disorder. Schizophr Res. 2009;110(1–3):47–58. [PubMed]
58. Joyal CC, Putkonen A, Mancini-Marie A, et al. Violent persons with schizophrenia and comorbid disorders: a functional magnetic resonance imaging study. Schizophr Res. 2007;91(1–3):97–102. [PubMed]
59. Krakowski MI, Convit A, Jaeger J, et al. Neurological impairment in violent schizophrenic inpatients. Am J Psychiatry. 1989;146(7):849–853. [PubMed]
60. Fresan A, Apiquian R, Nicolini H, et al. Temperament and character in violent schizophrenic patients. Schizophr Res. 2007;94(1–3):74–80. [PubMed]
61. Serper M, Beech DR, Harvey PD, et al. Neuropsychological and symptom predictors of aggression on the psychiatric inpatient service. J Clin Exp Neuropsychol. 2008;30(6):700–709. [PubMed]
62. Potkin S, Anand R, Alphs L, et al. Neurocognitive performance does not correlate with suicidality in schizophrenic and schizoaffecive patients at risk for suicide. Schizophr Res. 2002;59:59–66. [PubMed]
63. Raust A, Slama F, Mathieu F, et al. Prefrontal cortex dysfunction in patients with suicidal behavior. Psychol Med. 2007;37:411–419. [PubMed]
64. Enticott PG, Ogloff JR, Bradshaw JL, et al. Cognitive inhibitory control and self-reported impulsivity among violent offenders with schizophrenia. J Clin Exp Neuropsychol. 2008;30(2):157–162. [PubMed]
65. Norstrom T. Alcohol and homicide in the United States: is the link dependent on wetness? Drug Alcohol Rev. 2011;30(5):458–465. [PMC free article] [PubMed]
66. Fullam RS, Dolan MC. Executive function and in-patient violence in forensic patients with schizophrenia. Br J Psychiatry. 2008;193(3):247–253. [PubMed]
67. Jollant F, Bellivier F, Leboyer M, et al. Impaired decision making in suicide attempters. Am J Psychiatry. 2005;162(2):304–310. [PubMed]
68. Jollant F, Guillaume S, Jaussent I, et al. Impaired decision-making in suicide attempters may increase the risk of problems in affective relationships. J Affect Disord. 2007;99(1–3):59–62. [PubMed]
69. Keilp JG, Gorlyn M, Oquendo MA, et al. Attention deficit in depressed suicide attempters. Psychiatry Res. 2008;159(1–2):7–17. [PMC free article] [PubMed]
70. Westheide J, Quednow BB, Kuhn KU, et al. Executive performance of depressed suicide attempters: the role of suicidal ideation. Eur Arch Psychiatry Clin Neurosci. 2008;258(7):414–421. [PubMed]
71. Harkavy-Friedman JM, Keilp JG, Grunenbaum MF, et al. Are BPI and BPII suicide attempters distinct neuropsychologically? J Affect Disord. 2006;94:255–259. [PubMed]
72. Richard-Devantoy S, Jollant F, Kefi Z, et al. Deficit of cognitive inhibition in depressed elderly: a neurocognitive marker of suicidal risk. J Affect Disord. 2012;140(2):193–199. [PubMed]
73. Dolan MC, Fullam RS. Psychopathy and functional magnetic resonance imaging blood oxygenation level-dependent responses to emotional faces in violent patients with schizophrenia. Biol Psychiatry. 2009;66(6):570–577. [PubMed]
74. Hoptman MJ, Volavka J, Johnson G, et al. Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study. Biol Psychiatry. 2002;52(1):9–14. [PubMed]
75. Yang Y, Raine A. Prefrontal structural and functional brain imaging findings in antisocial, violent, and psychopathic individuals: a meta-analysis. Psychiatry Res. 2009;174(2):81–88. [PMC free article] [PubMed]
76. Naudts K, Hodgins S. Neurobiological correlates of violent behavior among persons with schizophrenia. Schizophr Bull. 2006;32(3):562–572. [PMC free article] [PubMed]
77. Monkul ES, Hatch JP, Nicoletti MA, et al. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol Psychiatry. 2007;12(4):360–366. [PubMed]
78. Jollant F, Lawrence NS, Olie E, et al. Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. Neuroimage. 2010;51(3):1275–1281. [PubMed]
79. Klempan TA, Sequeira A, Canetti L, et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry. 2009;14(2):175–189. [PubMed]
80. Fornito A, Zalesky A, Pantelis C, et al. Schizophrenia, neuroimaging and connectomics. Neuroimage. 2012;62(4):2296–2314. [PubMed]

Articles from Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie are provided here courtesy of SAGE Publications